|
|
|
Insider
Information: |
Leung Sandra |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
348,885 |
|
Indirect Shares
|
100,721 |
|
|
Direct
Value |
$14,274,050 |
|
|
Indirect Value
|
$4,138,626 |
|
|
Total
Shares |
449,606 |
|
|
Total
Value |
$18,412,676 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
7.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bristol-Myers Squibb Co |
BMY |
EVP, General Counsel |
2024-03-10 |
347,385 |
2024-03-10 |
100,721 |
Premium* |
|
Mead Johnson Nutrition Co |
MJN |
Director |
2009-02-17 |
1,500 |
2009-02-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
133 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2018-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,540 |
441,948 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2019-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
45,170 |
558,854 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2019-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,509) |
534,266 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2020-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,096 |
591,284 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2020-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(298) |
555,623 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2020-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
51,598 |
588,175 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2021-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,554 |
387,579 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2021-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(413) |
351,776 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2021-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,373 |
383,564 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
18,288 |
403,642 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2022-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
60,273 |
388,747 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2023-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
8,731 |
361,160 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2023-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
57,990 |
356,920 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2024-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
46,784 |
371,312 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2024-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(14,153) |
359,080 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP and General Counsel |
|
2009-03-02 |
4 |
D |
$17.74 |
$3,335 |
D/D |
(188) |
16,351 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP and General Counsel |
|
2009-03-01 |
4 |
D |
$18.41 |
$3,461 |
D/D |
(188) |
16,539 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP and General Counsel |
|
2008-03-01 |
4 |
D |
$22.61 |
$4,251 |
D/D |
(188) |
14,013 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP and General Counsel |
|
2008-03-02 |
4 |
D |
$22.61 |
$4,251 |
D/D |
(188) |
13,825 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP and General Counsel |
|
2010-03-01 |
4 |
D |
$24.57 |
$5,135 |
D/D |
(209) |
13,785 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP and General Counsel |
|
2009-03-06 |
4 |
D |
$18.35 |
$5,450 |
D/D |
(297) |
16,054 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
officerTitle |
|
2007-03-02 |
4 |
D |
$26.42 |
$5,865 |
D/D |
(222) |
14,386 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP and General Counsel |
|
2008-03-07 |
4 |
D |
$21.88 |
$6,498 |
D/D |
(297) |
13,528 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP and General Counsel |
|
2010-03-07 |
4 |
D |
$24.60 |
$10,258 |
D/D |
(417) |
40,090 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
SVP and General Counsel |
|
2008-07-07 |
4 |
D |
$20.60 |
$13,926 |
D/D |
(676) |
12,852 |
0 |
- |
|
133 Records found
|
|
Page 3 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|